C2N Diagnostics

FDA grants AbbVie's anti-tau drug orphan status
BioPharma Dive
Mon, 07/20/15 - 11:07 am
FDA
AbbVie
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
C2N Diagnostics